Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo  by Guimarães, Carla P. et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1689 (2004) 235–243Mouse liver PMP70 and ALDP: homomeric interactions
prevail in vivo
Carla P. Guimara˜esa,b, Pedro Dominguesc, Patrick Aubourgd, Francoise Fouquetd,
Aurora Pujole, Gerardo Jimenez-Sanchezf, Clara Sa´-Mirandaa,g, Jorge E. Azevedoa,b,*
a Instituto de Biologia Molecular e Celular, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal
b Instituto de Cieˆncias Biome´dicas de Abel Salazar, Largo do Prof. Abel Salazar, 2, 4099-003 Porto, Portugal
cDepartamento de Quı´mica, Universidade de Aveiro, Campo Santiago, 3810-193 Aveiro, Portugal
dHoˆpital Saint Vincent de Paul, 82 Avenue Denfert-Rochereau, 75014 Paris, France
e Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/ULP, B.P. 163, 67404 Illkirch Cedex, C.U. de Strasbourg, France
fDepartment of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
g Instituto de Gene´tica Me´dica Jacinto de Magalha˜es, Praca Pedro Nunes, 88, 4050-466 Porto, PortugalReceived 19 December 2003; received in revised form 29 March 2004; accepted 2 April 2004
Available online 24 April 2004Abstract
ALDP, ALDPR, PMP70 and PMP70R are half ATP-binding cassette (ABC) transporters of the mammalian peroxisomal membrane. By
analogy with other members of this family, it is assumed that peroxisomal ABC transporters must dimerize to become functional units.
However, not much is known regarding the type of dimers (i.e., homodimers and/or heterodimers) that are formed in vivo under normal
expression conditions. In this work, we have characterized the quaternary structure of mouse liver PMP70 and ALDP. The PMP70 protein
complex was purified to apparent homogeneity using a two-step purification protocol. The ALDP-containing protein complex was
characterized by preparative immunoprecipitation experiments. In both cases, no evidence for the existence of heteromeric interactions or for
the presence of accessory proteins in these ABC transporter protein complexes could be obtained. Our data indicate that the majority (if not
all) of mouse liver PMP70 and ALDP are homomeric proteins.
D 2004 Elsevier B.V. All rights reserved.Keywords: Half ABC transporter; Peroxisome; Adrenoleukodystrophy; X-ALD; Membrane protein purification
1. Introduction transmembrane domains, each comprising several a-helices,The ATP-binding cassette transporters (ABC transport-
ers) represent one of the largest families of proteins, with 48
ABC transporters already identified in human. These pro-
teins are molecular pumps that couple ATP hydrolysis to the
transport of substrates (e.g., cholesterol, bile salts, polypep-
tides, iron) across biological membranes (reviewed in Ref.
[1]). Structurally, the members of this family have two0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2004.04.001
Abbreviations: ABC, ATP-binding cassette; ALDP, adrenoleukodys-
trophy protein; ALDPR, ALDP-related protein; PMP70, peroxisomal
membrane protein of 70 kDa; PMP70R, PMP70-related protein; X-ALD,
X-linked adrenoleukodystrophy; ESI-MS, electrospray ionization mass
spectrometry
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E-mail address: jazevedo@ibmc.up.pt (J.E. Azevedo).and two conserved nucleotide binding domains (reviewed in
Ref. [2]). In eukaryotes, the ABC proteins are classified
either as full transporters, if this core of four domains is
encoded by only one gene (e.g., CFTR), or as half-trans-
porters, if the corresponding genes encode only one trans-
membrane domain and one nucleotide binding domain (e.g.,
Tap1 and Tap2). The latter class of proteins becomes
functional only after dimerization (reviewed in Ref. [3]).
In mammals, four half ABC transporters are present in
the peroxisomal membrane: the adrenoleukodystrophy pro-
tein (ALDP or ABCD1 [4]), the ALDP-related protein
(ALDPR or ABCD2 [5]), the peroxisomal membrane protein
of 70 kDa (PMP70 or ABCD3 [6]) and the PMP70-related
protein (PMP70R or ABCD4 [7,8]). By analogy with other
members of the half ABC transporter family (e.g., Tap1 and
Tap2), it has been assumed for long that these peroxisomal
transporters must dimerize to become functional units.
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dimers only or if heterodimers can also be formed is an issue
that did not receive much attention up to now. In fact,
although all these peroxisomal proteins were identified
several years ago, only three studies have addressed this
problem. In one of these studies, yeast two-hybrid experi-
ments together with Western blotting analysis of immuno-
precipitates obtained from cultured cells overexpressing
peroxisomal transporters led to the idea that ALDP, ALDPR
and PMP70 are quite promiscuous entities capable of
engaging in both homo- and heterodimerization processes
[9]. However, due to the nature of the experimental techni-
ques used in that study, it is not evident what kind of
interactions prevails in vivo (i.e., under normal expression
conditions of the peroxisomal transporters). Exactly the
same remark can be made regarding the in vitro experiments
described by Smith et al. [10]. In that work, a co-immuno-
precipitation assay employing in vitro synthesized proteins
was used to identify protein–protein interactions involving
ALDP, PMP70 and ALDPR. Finally, in the third study
addressing this issue, purified peroxisomes from rat liver
were used in immunoprecipitation experiments. The authors
were able to demonstrate co-immunoprecipitation of ALDP
with PMP70 [11]. However, several other peroxisomal
proteins were also found in the immunoprecipitates. Thus,
it is not clear whether the PMP70–ALDP interaction is
direct or indirect.
Defining the kind of protein interactions in which per-
oxisomal transporters are involved in vivo is an important
task having major implications on our knowledge on the
biochemistry of the mammalian peroxisome. If it is assumed
that peroxisomal transporters exist in the peroxisomal mem-
brane solely as homodimers, then only four different sub-
strates (or families of substrates) are expected to be
transported by these proteins. If, however, peroxisomal
transporters are promiscuous entities capable of interacting
with each other, then 10 different combinations of trans-
porters can be formed raising the possibility that 10 different
substrates (or families of substrates) use these transporters to
cross the peroxisomal membrane. In the particular case of
ALDP, it is likely that such information is of fundamental
importance to understand the pathogenesis mechanism in X-
linked adrenoleukodystrophy (X-ALD), a human genetic
disease caused by mutations in the ALDP gene (reviewed in
Ref. [12]) and that affects 1:21,000–1:100,000 males
[13,14].
Although the exact function of ALDP is not presently
known, it has been proposed that it transports very long
chain fatty acids (VLCFAs) into the peroxisomal compart-
ment or some factor necessary for the peroxisomal h-
oxidation of these compounds [4,15]. This conclusion
derives from the fact that X-ALD patients accumulate
VLCFAs in many organs (liver included [16]) and body
fluids (reviewed in Ref. [12]), a biochemical alteration that
was also observed in several ALD knockout mice [16–18].
However, the correlation between accumulation of VLCFAsand clinical phenotype in X-ALD is far from being clear
[19], raising the possibility that other (still unknown)
biochemical factors contribute to the pathology. To define
the biochemical role of ALDP, it is of the utmost importance
to know the kind of protein–protein interactions in which
ALDP is involved in vivo. If ALDP is a homodimeric
protein, then only one primary biochemical defect should
occur in the absence of a functional protein. If, however,
ALDP is capable of forming homo- and heterodimers, then
it is plausible to assume that the metabolism of more than
one type of substrates will be affected by the absence of
functional ALDP.
In this work, we have characterized the quaternary
structure of mouse liver PMP70 and ALDP. After solubili-
zation of peroxisomal proteins using the mild detergent
digitonin, a simple two-step procedure was used to purify
PMP70. The ALDP protein complex was characterized by
preparative immunoprecipitation experiments. Our results
indicate that both half ABC transporters exist in the perox-
isomal membrane predominantly (if not exclusively) as
homomeric proteins, probably dimers.2. Materials and methods
2.1. Purification of mouse liver peroxisomes
Peroxisomes were isolated from the liver of C57/BL6
male mice (1–3 months of age) by differential centrifuga-
tion and purified through a Nycodenz gradient essentially
as described [20,21]. The Nycodenz gradients (6 ml of
30% and 2 ml of 25% (w/v) Nycodenz in 5 mM imidaz-
ole–HCl, pH 7.4 and 1 mM EDTA–NaOH, pH 7.4) were
centrifuged in the fixed-angle rotor T1270 (Sorvall, Ultra
Pro80 centrifuge) at 60000 g for 30 min. Peroxisomes
obtained in this way were estimated to be 90% pure
presenting a minor contamination with mitochondria and
endoplasmic reticulum.
2.2. Solubilization of peroxisomal proteins
In a typical experiment, 1 mg of purified peroxisomes
were incubated in 500 Al of solubilization buffer (see
bellow) for 30 min at 4 jC with gentle agitation. Protein
samples were centrifuged at 105000 g for 1 h at 4 jC
using the rotor T1270. To determine yields of solubiliza-
tion, equivalent portions of supernatants and pellets were
subjected to Western blotting analysis using antibodies
directed to mouse peroxisomal ABC transporters. Good
solubilization yields (approximately 80%) were obtained
when using a buffer (hereafter referred to as buffer A)
containing 1% (w/v) digitonin [added from a 5% (w/v)
stock solution prepared as suggested by the manufacturer
(Calbiochem)], 50 mM Tris–acetic acid, pH 7.5, 0.1 M
potassium acetate-acetic acid, pH 7.4, 0.25 M 6-amino-
caproic acid, 1 mM EDTA–NaOH, pH 7.4, 1:500 (v/v)
C.P. Guimara˜es et al. / Biochimica et Bioprotease inhibitor cocktail (Sigma P8340) and 0.1 mg/ml
phenylmethylsulfonyl fluoride.
2.3. Sucrose density gradient analysis
Detergent-solubilized proteins (2 mg of protein in 1 ml of
buffer A) were loaded onto the top of a discontinuous
sucrose gradient [2 ml of 10%, 1.8 ml of 15.5%, 1.7 ml
of 21%, 1.5 ml of 25%, 1.2 ml of 30%, 1.0 ml of 35% and
0.3 ml of 40% (w/v) sucrose in a buffer containing 50 mM
Tris–acetic acid, pH 7.5, 10 mM potassium acetate–acetic
acid, pH 7.4, 1 mM EDTA–NaOH pH 7.4 and 0.1% (w/v)
digitonin]. In the experiment shown in Fig. 1, centrifugation
of the sucrose gradients was performed in the swinging
bucket rotor TST 41.14 rotor (Sorvall, OTD75B centrifuge)
at 160000 g for 16 h at 4 jC. In Fig. 2, the sucrose
gradient was centrifuged at 180000 g for 16 h at 4 jC
using the swinging bucket rotor TH-641 (Sorvall, Ultra
Pro80 centrifuge). Twelve fractions of 875 Al were collected
from the bottom of the tube and subjected to precipitation
with 10% (w/v) trichloroacetic acid.
Treatment with urea of digitonin-solubilized peroxisomal
proteins was done as follows: 200 Ag of purified perox-
isomes were incubated with 50 Al of buffer A for 15 min at 4
jC with gentle agitation. After adding 25 Al of 9 M urea
(final concentration of 3 M), protein samples were incubated
15 min at room temperature, diluted with 925 Al of buffer A
and loaded onto the top of a sucrose gradient.Fig. 1. Sedimentation analysis of digitonin-solubilized mouse liver ALDP, PMP70
onto the top of a sucrose gradient. After centrifugation, the gradient was fractionat
of each fraction (corresponding to 210 Ag of peroxisomal protein) were precipitated
directed to ALDP, PMP70, ALDPR and the a subunit (F1a) of the mitochondrial A
kDa) and palmitoyl-CoA oxidase (150 kDa) in the gradient are also indicated. La
proteins (200 Ag) were incubated in the presence of 3 M urea, subjected to sucro2.4. Purification of mouse liver PMP70 complex
The purification protocol was started with a pellet of 3.3
mg of purified peroxisomes. The organelles were solubi-
lized for 30 min at 4 jC, in 550 Al of buffer B (buffer A
without EDTA, plus 2 mM MgCl2 and 0.5 mM MnCl2). The
sample was subjected to centrifugation at 105000 g for 1
h at 4 jC to remove insoluble material. The supernatant was
added to 150 Al (bed volume) of ATP-agarose (C-8 attach-
ment; Sigma) previously equilibrated in buffer C (buffer B
containing 0.1% (w/v) digitonin). After incubation for 1 h at
4 jC in an end-over-end shaker, the ATP-agarose slurry was
washed twice with 1.5 ml of buffer C supplemented with 5
mM MgCl2 (final concentration). The proteins were then
eluted with 600 Al of buffer C containing 10 mMMgCl2 and
10 mM ATP for 1 h at 4 jC with occasional shaking. Eluted
proteins were loaded onto the top of a sucrose gradient
(rotor TH-641), centrifuged and fractionated, as described
above.
2.5. Immunoprecipitation of mouse liver ALDP
Two milligrams of purified peroxisomes were solubilized
in 2 ml of buffer A containing 5 mM iodoacetamide for 30
min at 4 jC and subjected to centrifugation (105000 g for
1 h at 4 jC) to remove insoluble material. One aliquot (220
Al) of the supernatant (sample ‘‘T’’) was kept on ice. The
remaining supernatant was halved. Each half was added to
physica Acta 1689 (2004) 235–243 237and ALDPR. (A) Digitonin-solubilized peroxisomal proteins were loaded
ed starting from the bottom (lane 1) to the top (lane 12). Equivalent portions
with trichloroacetic acid and analyzed by immunoblotting using antibodies
TPase complex (molecular mass of 750 kDa). The positions of catalase (240
ne T, 70 Ag of peroxisomal protein. (B) Digitonin-solubilized peroxisomal
se gradient centrifugation and analyzed as described above.
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been previously coupled with anti-ALDP or pre-immune
immunoglobulins G (IgGs; see below). The samples were
incubated for 3 h at 4 jC, in an end-over-end shaker. The
beads were collected by centrifugation (10000 g for 10
s) and the supernatants (samples ‘‘S’’) were removed andkept on ice. After washing the beads four times with 1
ml of buffer A containing 0.1% (w/v) digitonin, immu-
noprecipitated proteins were eluted with 150 Al of
Laemmli sample buffer [22] at 85 jC for 10 min. Fifteen
microliters of 1 M dithiothreitol were subsequently added
to the eluate. Samples ‘‘T’’ and ‘‘S’’ were subjected to
C.P. Guimara˜es et al. / Biochimica et Biophysica Acta 1689 (2004) 235–243 239precipitation with trichloroacetic acid before SDS-PAGE
analysis.
2.6. Electrospray ionization mass spectrometry (ESI-MS)
ESI-MS of tryptic digests from protein-containing poly-
acrylamide gel slices was carried out using a Q-TOF 2
mass spectrometer (Micromass, Manchester, UK). Samples
were digested as described [23] and analyzed by HPLC-
MS using a Discovery Bio Wide Pore C18, 5 mm (15
cm 0.32 mm) HPLC column (Supelco, Bellefonte, USA).
Proteins were identified by search with peptide-mass
fingerprinting data from mass spectrometry on Protein
Prospector [24].
2.7. Miscellaneous
Proteins were quantified by the Lowry method, using
albumin as standard [25]. SDS-PAGE analysis was per-
formed in 0.75-mm-thick, 11% polyacrylamide gels using
the Laemmli discontinuous buffer system [22]. Silver stain-
ing of polyacrylamide gels was performed as described [26].
Western blotting onto nitrocellulose membranes was done as
described by the manufacturer (Schleicher & Schuell). The
polyclonal antibodies directed to mouse ALDP (serum 1664
[27]) and ALDPR (serum 7373 [28]) were used in immu-
noblotting analysis at 1:1000 (v/v) dilution. The rabbit
antibody directed to rat PMP70 (Zymed Laboratories) and
the mouse anti-a subunit of the mitochondrial ATPase
complex (Molecular Probes) were used in immunoblotting
analysis at 1:2000 (v/v) dilution. The primary antibodies
were detected with a horseradish peroxidase conjugated
donkey antirabbit or sheep antimouse antibodies (Amer-
sham Biosciences) using ECL super signal West-dura sub-
strates (Pierce).
Control and antimouse ALDP IgGs were isolated using
protein A-Sepharose according to the manufacturer’s
instructions (Amersham Biosciences). The isolated IgGs
were coupled to CNBr-activated Sepharose 4B beads at a
ratio of 200 Ag of protein per 12 mg of resin following the
manufacturer’s recommendations (Amersham Biosciences).
Densitometric analysis of Western blots was performed
using the UN-SCAN-IT automated digitizing system.Fig. 2. Isolation of the PMP70-containing protein complex. (A) Digitonin-solubiliz
subjected to an ATP-agarose affinity chromatography. Eluted proteins (lane E, der
and centrifuged. The PMP70-enriched fraction (fraction 4 of the sucrose gradient; s
Lane T, 2 Ag of peroxisomal protein. Lane MW, molecular mass markers. A
chromatography eluted proteins (derived from 250 Ag of peroxisomal proteins) w
stained gel and the lower panel a Western blotting using the PMP70, ALDP and A
MS (see also Table 1): a—mitochondrial ATP-synthase a-chain, a subunit of the 75
a homodimer of 154 kDa [35]; d—peroxisomal L-bifunctional protein, a 79-kDa
trimeric form [37]). Some other proteins can be easily identified considering their
and 21 kDa subunits of palmitoyl-CoA oxidase, respectively, a dimeric protein
complex of 240 kDa [39]. Arrows A and B on the left indicate the expected mi
molecular mass standards (kDa) are indicated.3. Results
3.1. Mouse liver PMP70, ALDP and ALDPR behave as
large protein complexes upon solubilization with digitonin
As a first step to characterize the quaternary structure of
peroxisomal half ABC transporters, a preliminary set of
experiments was performed to find the best solubilization
conditions. These experiments were carried out taking into
consideration two variables: (1) high yield in the solubili-
zation procedure, so that the extracted protein population is
representative of the population that exists in vivo and (2)
mildness of the solubilization step to avoid disrupting
protein–protein interactions. The first variable was quanti-
fied by densitometric analysis of Western blots containing
known amounts of total peroxisomal proteins and the
corresponding solubilized protein fractions; yields of 80%
were routinely obtained (compare lanes Per and T in Fig. 3).
The second variable was empirically assessed by subjecting
solubilized proteins to centrifugation sedimentation analysis
(see below).
For practical reasons, related to antibody availability and
facility in obtaining highly purified peroxisomal fractions,
these studies were performed with mouse liver proteins. The
results of one of these experiments are shown in Fig. 1A.
After solubilization of purified mouse liver peroxisomes
using the mild detergent digitonin, PMP70, ALDP and
ALDPR were found as large protein complexes (apparent
molecular mass of 300–400 kDa) upon sucrose gradient
centrifugation. Considering that all these proteins have a
predicted molecular mass around 70 kDa, the estimated
molecular masses may appear too large even if we assume
that all these proteins are indeed in a dimeric state. How-
ever, it should be noted that the sedimentation properties of
a solubilized membrane protein also depend on its partial
specific volume, shape and amount and type of protein-
bound detergents/membrane lipids. Thus, no conclusions
regarding the true size of the observed protein complexes
can be inferred from these experiments. In fact, by the same
line of reasoning, it could be argued that the solubilized
proteins are in the monomeric state. However, this is clearly
not the case as shown by the following experiment. Digi-
tonin-solubilized peroxisomal proteins were incubated in theed peroxisomal proteins (lane S, derived from 2 Ag of starting material) were
ived from 8 Ag of peroxisomal protein) were loaded onto a sucrose gradient
ee below) was selected (lane F; derived from 80 Ag of peroxisomal protein).
silver-stained polyacrylamide gel is shown. (B) ATP-agarose affinity
ere subjected to sedimentation analysis. The upper panel shows a silver-
LDPR antibodies. The identity of several proteins was determined by ESI-
0 kDa complex V [34]; b—PMP70; c—peroxisomal D-bifunctional protein,
protein monomeric in its native state [36]; e—urate oxidase (probably the
abundance, molecular mass and subunit composition: f1, f2 and f3—72, 52
with a native molecular mass of 150 kDa [38]; g—catalase, a tetrameric
gration positions of ALDP and ALDPR, respectively. The positions of the
Fig. 3. Characterization of the ALDP-containing protein complex.
Digitonin-solubilized peroxisomal proteins (lane T) were incubated with
CNBr-activated Sepharose 4B beads previously coupled to control or anti-
ALDP IgGs (see Materials and methods). After centrifugation, the
supernatants were recovered, the beads were washed and the immunopre-
cipitated proteins were eluted with Laemmli sample buffer. Lanes S1 and
I1: supernatant and immunoprecipitated proteins, respectively, obtained
with control IgGs. Lanes S2 and I2: supernatant and immunoprecipitated
proteins obtained with anti-ALDP IgGs, respectively. The protein samples
were subjected to Western blotting using antibodies directed to ALDP,
ALDPR and PMP70 (panel A) or analyzed by SDS-PAGE followed by
silver staining (panel B). In panel A, protein loading was the following:
lanes T, S1 and S2—proteins derived from 70 Ag of peroxisomal protein;
lanes I1 and I2—immunoprecipitated proteins derived from 140 Ag of
peroxisomal protein; lane Per: 70 Ag of peroxisomal protein. In panel B,
aliquots derived from 2 Ag of peroxisomal protein were loaded in lanes T,
S1 and S2. Lanes I1 and I2 contain immunoprecipitated proteins from 140
Ag of peroxisomal protein. Lane Per—2 Ag of peroxisomal proteins.
Arrows a and b indicate the expected migration positions of ALDPR and
PMP70, respectively. Molecular mass markers are shown on the left-hand
lane (lane MW). Table 1
Identification of ATP-agarose affinity chromatography purified proteins
using ESI-MS
Protein
band
Protein name MW (Da) Mean error
(ppm)
Sequence
coverage
(%)
MOWSE
scorea
A ATP synthase
alpha chain
59,753 8.9 32.0 1.216e + 008
B PMP70 75,483  15.1 19.0 4.619e + 007
C Peroxisomal
D-bifunctional
enzyme
79,525  3.25 18.0 1.928e + 007
D Peroxisomal
L-bifunctional
enzyme
78,244 0.534 22.0 1.896e + 007
E Urate oxidase 35,039 14.0 32.0 5.289e + 006
a The MOWSE score reported by MS-Fit is based on the scoring system
described in Ref. [40].
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disrupt protein–protein interactions. After diluting the so-
lution with digitonin-containing buffer (see Materials and
methods), the protein sample was subjected to sedimenta-
tion analysis. Although a fraction of several peroxisomal
proteins precipitated after this treatment and were found at
the bottom of the centrifuge tube (data not shown), a small
amount of PMP70 and ALDP remained soluble. Two
different populations of PMP70 were detected in this
experiment (see Fig. 1B): a minor fraction of PMP70
resisted to the urea treatment in an apparently intact con-
formation (fraction 4 of the gradient); the majority of
soluble PMP70, however, was found in fractions 7–8 of
the sucrose gradient (apparent molecular mass of 100–150kDa). Similar results were obtained for ALDP, although in
this case the vast majority of the protein was detected in
fraction 7–8 of the sucrose gradient (see Fig. 1B). These
data taken together indicate that under the solubilization
conditions employed, peroxisomal transporters are indeed
components of protein complexes.
3.2. Purification of mouse liver PMP70
As shown above, digitonin-solubilized PMP70, ALDP
and ALDPR behave as 300–400 kDa protein complexes
upon centrifugation sedimentation analysis. Such apparent
molecular mass could be explained by assuming that these
proteins are dimers that bind large amounts of detergent (see
Discussion). Alternatively, this behavior could reflect the
existence of larger protein complexes comprising, in addi-
tion to the transporters, other proteins. Examples of ABC
transporter protein complexes containing accessory proteins
are abundant (e.g., tapasin and the TAP transporter of
mammals [29]) or the maltose binding protein and the
ABC maltose transporter of Escherichia coli; reviewed in
Ref. [30]).
To clarify this issue, the PMP70-containing protein
complex was purified. For this purpose, a simple two-step
procedure was developed. In the first step, digitonin-solu-
bilized peroxisomal proteins were subjected to an ATP-
agarose affinity chromatography (see Materials and methods
for details). Western blotting analysis revealed that more
than 90% of the amount of PMP70 applied to the affinity
matrix was recovered after this step (data not shown).
Interestingly, several other proteins were specifically eluted
from the ATP-agarose matrix (see Figs. 2A and B and Table
1). Although some of these proteins may indeed bind ATP
(this is surely the case for mitochondrial complex V;
reviewed in Ref. [31]), the majority of the proteins identified
bind adenine-containing molecules (e.g., NADP, FAD,
NAD), but not ATP itself (see legend to Fig. 2). In the
second step of the purification procedure, the high sedimen-
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plored. As shown in Fig. 2A, a homogeneous PMP70
preparation was obtained: no stoichiometric amounts of
other proteins co-purifying with PMP70 could be detected
upon SDS-PAGE analysis. Furthermore, ESI-MS analysis of
the protein band containing PMP70 failed to reveal the
presence of any protein other than PMP70 itself. We
conclude that the majority of mouse liver PMP70 is a
homomeric protein.
It may be interesting to note that high amounts of PMP70
(5 Ag/mg of total peroxisomal protein) can be easily
obtained using the method described here. Biochemical
experiments to further characterize the structure/function
of this protein are under progress.
3.3. Characterization of the mouse liver ALDP protein
complex
In rat liver, ALDP and ALDPR are much less abundant
proteins than PMP70 [11]. This is probably also the case for
mouse liver ALDP and ALDPR. Indeed, although these two
mouse proteins are also retained in an ATP-agarose matrix,
as revealed by Western blot analysis (see Fig. 2B), no
protein band corresponding to either of these proteins can
be detected in the polyacrylamide gels shown in Fig. 2.
Thus, to characterize the quaternary structure of ALDP, a
different strategy was used. Digitonin-solubilized mouse
liver peroxisomes were subjected to an immunoprecipitation
experiment using the anti-ALDP antibody. Immunoprecipi-
tated proteins were then analyzed by Western blotting using
antibodies directed to ALDP, PMP70 and ALDPR. As
shown in Fig. 3A, about 80% of the ALDP protein was
immunoprecipitated by the anti-ALDP antibody. Most
importantly, neither PMP70 nor ALDPR could be detected
in the immunoprecipitate.
To corroborate these observations, the immunoprecipi-
tated proteins were also subjected to SDS-PAGE and stained
with silver. As shown in Fig. 3B, besides antibody-derived
protein bands, only one protein band displaying exactly the
electrophoretic behavior of ALDP is visible in the immu-
noprecipitate obtained with the anti-ALDP antibody. Taken
together, these data strongly suggest that the majority of
mouse liver ALDP (if not all) is a homomeric protein
assembly.4. Discussion
The most critical step in any protocol aiming at the
purification of a membrane protein resides in the solubili-
zation procedure. Solubilization conditions have to ensure
high yields in the extraction of the protein(s) under study,
and, if the aim is to isolate protein complexes, they have to
be gentle enough so that protein–protein interactions are
preserved. When determining the best solubilization con-
ditions for a given protein it is important to define thevariable ‘‘solubility’’. In general terms, a soluble protein
should remain in the supernatant after centrifugation for 1
h at 105000 g or should elute in the included volume
from a gel filtration medium with very large pores such as
Sepharose 4B [32]. In this work, we used the former
criterion. Unfortunately, these considerations are sometimes
overlooked and it is not uncommon to find in the literature
experiments involving membrane proteins in which the
detergent extract was just subjected to a low speed centri-
fugation (e.g., 5 min at 15000 g) before immunoprecip-
itation. The risk associated with this type of procedure is
high: If the protein under study is not completely in
solution, then it is likely that other insoluble proteins will
be co-immunoprecipitated not because they are truly asso-
ciated with the protein of interest but because they reside in
the same membrane fragments. This is probably the reason
why the data reported here are so different from recent
results suggesting that rat liver PMP70 and ALDP are
components of the same protein assembly [11].
The aim of the work presented here was to determine the
type of protein–protein interactions in which peroxisomal
half ABC transporters are involved in vivo. In particular, we
were interested in assessing whether these transporter pro-
teins can engage in heteromeric interactions with each other
and/or with other unrelated proteins under normal expres-
sion conditions. It should be noted that data suggesting that
all these peroxisomal ABC transporters interact with each
other have already been described. Indeed, pairwise inter-
actions involving PMP70, ALDP and ALPR were observed
when using a combination of yeast two-hybrid assays and
Western blotting analysis of immunoprecipitates obtained
from cultured cells overexpressing epitope-tagged peroxi-
somal transporters [9]. While these results suggest that these
proteins have the potential to interact with each other
forming both homo- and heterodimers, the nonquantitative
nature of these techniques does not allow us to infer which
kind of interactions (if any) prevail in vivo.
Considering the unexpectedly high apparent molecular
mass of digitonin-solubilized peroxisomal ABC transporters
(300–400 kDa), we started our studies by addressing the
possibility that these transporters interact with other non-
related proteins. For this purpose, we isolated chemical
amounts of the PMP70-containing complex. Our results
clearly show that no other protein in stoichiometric amounts
was co-purified with PMP70. Thus, the strikingly high
sedimentation coefficient of PMP70 (and of the other two
ABC transporters characterized in this work) is an intrinsic
property of these digitonin-solubilized proteins. What is the
reason for such high sedimentation coefficients? The most
plausible explanation is to assume that all these proteins are
dimers (approximate molecular masses of 140 kDa) that
bind an amount of detergent that equals 100–150% of their
masses (140–210 kDa). Detergent/protein ratios of 1:1.5
(w/w) are quite common for solubilized hydrophobic pro-
teins (e.g., Ref. [33]). The fact that the majority of urea-
treated PMP70 and ALDP (presumably representing mono-
C.P. Guimara˜es et al. / Biochimica et Biophysica Acta 1689 (2004) 235–243242meric protein) display an apparent molecular mass of 100–
150 kDa supports this interpretation. However, it has to be
emphasized that further experiments are necessary to con-
firm this hypothesis. Thus, at this moment, other possibil-
ities (e.g., a homotetrameric structure), although unlikely,
cannot be formally excluded.
To assess whether peroxisomal ABC transporters are
capable of forming heterodimers, we focused our attention
on ALDP. To characterize the quaternary structure of this
protein, we performed immunoprecipitation experiments
using mouse liver peroxisomes. Western blotting analysis
clearly show that neither PMP70 nor ALDPR could be co-
immunoprecipitated with ALDP. Silver staining of a poly-
acrylamide gel containing the immunoprecipitated proteins
confirmed this observation: No protein band other than the
one corresponding to ALDP could be observed. Thus, the
vast majority (if not all) of mouse liver ALDP is a
homomeric protein.
Due to the fact that antibodies directed to mouse
PMP70R are not yet available, the properties of this protein
regarding its native molecular mass and interactions with the
other three peroxisomal half ABC transporters could not be
assessed in this work. Although there are no data whatso-
ever to support the existence of heteromeric interactions
involving PMP70R, our data do not allow us to exclude this
possibility. Indeed, PMP70R is much less abundant than
PMP70 and ALDP (less than 1/70 and 1/10, respectively
[11]) and thus, the presence of PMP70R in our silver-stained
gels would not be noted. Further work is necessary to clarify
this issue.
In conclusion, our results indicate that mouse liver
PMP70 and ALDP are mostly (if not exclusively) homo-
meric protein assemblies. Determining whether this obser-
vation can be extended to other mouse organs and to other
organisms, humans in particular, is of main importance to
understand the pathophysiology of X-ALD.Acknowledgements
This work was supported by Fundaca˜o para a Cieˆncia e
Tecnologia, Portugal and FEDER. C.P.G. is a recipient of a
scholarship from Fundaca˜o para a Cieˆncia e Tecnologia,
Portugal (SFRH/BD/1445/2000).References
[1] M. Dean, Y. Hamon, G. Chimini, The human ATP-binding cassette
(ABC) transporter superfamily, J. Lipid Res. 42 (2001) 1007–1017.
[2] I.D. Kerr, Structure and association of ATP-binding cassette transport-
er nucleotide-binding domains, Biochim. Biophys. Acta 1561 (2002)
47–64.
[3] P.M. van Endert, L. Saveanu, E.W. Hewitt, P. Lehner, Powering the
peptide pump: TAP crosstalk with energetic nucleotides, Trends Bio-
chem. Sci. 27 (2002) 454–461.
[4] J. Mosser, A.M. Douar, C.O. Sarde, P. Kioschis, R. Feil, H. Moser,A.M. Poustka, J.L. Mandel, P. Aubourg, Putative X-linked adreno-
leukodystrophy gene shares unexpected homology with ABC trans-
porters, Nature 361 (1993) 726–730.
[5] G. Lombard-Platet, S. Savary, C.O. Sarde, J.L. Mandel, G. Chimini,
A close relative of the adrenoleukodystrophy (ALD) gene codes for a
peroxisomal protein with a specific expression pattern, Proc. Natl.
Acad. Sci. U. S. A. 93 (1996) 1265–1269.
[6] K. Kamijo, S. Taketani, S. Yokota, T. Osumi, T. Hashimoto, The 70-
kDa peroxisomal membrane protein is a member of the Mdr (P-gly-
coprotein)-related ATP-binding protein superfamily, J. Biol. Chem.
265 (1990) 4534–4540.
[7] A. Holzinger, S. Kammerer, A.A. Roscher, Primary structure of hu-
man PMP69, a putative peroxisomal ABC-transporter, Biochem. Bio-
phys. Res. Commun. 237 (1997) 152–157.
[8] N. Shani, G. Jimenez-Sanchez, G. Steel, M. Dean, D. Valle, Identifi-
cation of a fourth half ABC transporter in the human peroxisomal
membrane, Hum. Mol. Genet. 6 (1997) 1925–1931.
[9] L.X.Liu,K.Janvier,V.Berteaux-Lecellier,N.Cartier,R.Benarous,Aubourg,
Aubourg, P. Aubourg, Homo- and heterodimerization of peroxi-
somal ATP-binding cassette half-transporters, J. Biol. Chem. 274
(1999) 32738–32743.
[10] K.D. Smith, S. Kemp, L.T. Braiterman, J.F. Lu, H.M. Wei, M. Ger-
aghty, G. Stetten, J.S. Bergin, J. Pevsner, P.A. Watkins, X-linked
adrenoleukodystrophy: genes, mutations, and phenotypes, Neuro-
chem. Res. 24 (1999) 521–535.
[11] A.R. Tanaka, K. Tanabe, M. Morita, M. Kurisu, Y. Kasiwayama, M.
Matsuo, N. Kioka, T. Amachi, T. Imanaka, K. Ueda, ATP binding/
hydrolysis by and phosphorylation of peroxisomal ATP-binding cas-
sette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein
(ABCD1), J. Biol. Chem. 277 (2002) 40142–40147.
[12] H.W. Moser, K.D. Smith, P.A. Watkins, J. Powers, A.B. Moser,
X-linked adrenoleukodystrophy, in: C.R. Scriver, A.L. Beaudet,
W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases
of Inherited Disease, eight ed., McGraw-Hill, New York, 2001,
pp. 3257–3302.
[13] L. Bezman, A.B. Moser, G.V. Raymond, P. Rinaldo, P.A. Watkins,
K.D. Smith, N.E. Kass, H.W. Moser, Adrenoleukodystrophy: inci-
dence, new mutation rate, and results of extended family screening,
Ann. Neurol. 49 (2001) 512–517.
[14] B.M. vanGeel, J. Assies, R.J. Wanders, P.G. Barth, X linked adreno-
leukodystrophy: clinical presentation, diagnosis, and therapy, J. Neu-
rol. Neurosurg. Psychiatry 63 (1997) 4–14.
[15] P. Aubourg, M. Dubois-Dalcq, X-linked adrenoleukodystrophy enig-
ma: how does the ALD peroxisomal transporter mutation affect CNS
glia? Glia 29 (2000) 186–190.
[16] J.F. Lu, A.M. Lawler, P.A. Watkins, J.M. Powers, A.B. Moser, H.W.
Moser, K.D. Smith, A mouse model for X-linked adrenoleukodys-
trophy, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9366–9371.
[17] S. Forss-Petter, H. Werner, J. Berger, H. Lassmann, B. Molzer, M.H.
Schwab, H. Bernheimer, F. Zimmermann, K.A. Nave, Targeted inac-
tivation of the X-linked adrenoleukodystrophy gene in mice, J. Neu-
rosci. Res. 50 (1997) 829–843.
[18] T. Kobayashi, N. Shinnoh, A. Kondo, T. Yamada, Adrenoleukodys-
trophy protein-deficient mice represent abnormality of very long
chain fatty acid metabolism, Biochem. Biophys. Res. Commun. 232
(1997) 631–636.
[19] A.B. Moser, N. Kreiter, L. Bezman, S. Lu, G.V. Raymond, S.
Naidu, H.W. Moser, Plasma very long chain fatty acids in 3,000
peroxisome disease patients and 29000 controls, Ann. Neurol. 45
(1999) 100–110.
[20] F.U. Hartl, W.W. Just, Integral membrane polypeptides of rat liver
peroxisomes: topology and response to different metabolic states,
Arch. Biochem. Biophys. 255 (1987) 109–119.
[21] A.M. Gouveia, C. Reguenga, M.E. Oliveira, C. Eckerskorn, C.
Sa-Miranda, J.E. Azevedo, Alkaline density gradient floatation of
membranes: polypeptide composition of the mammalian peroxisomal
membrane, Anal. Biochem. 274 (1999) 270–277.
C.P. Guimara˜es et al. / Biochimica et Biophysica Acta 1689 (2004) 235–243 243[22] U.K. Laemmli, Cleavage of structural proteins during the assembly of
the head of bacteriophage T4, Nature 227 (1970) 680–685.
[23] A. Shevchenko, M. Wilm, O. Vorm, M. Mann, Mass spectrometric
sequencing of proteins silver-stained polyacrylamide gels, Anal.
Chem. 68 (1996) 850–858.
[24] K.R. Clauser, P. Baker, A.L. Burlingame, Role of accurate mass mea-
surement (F 10 ppm) in protein identification strategies employing
MS or MS/MS and database searching, Anal. Chem. 71 (1999)
2871–2882.
[25] G.L. Peterson, Determination of total protein, Methods Enzymol. 91
(1983) 95–119.
[26] C.R. Merril, Gel-staining techniques, Methods Enzymol. 182 (1990)
477–488.
[27] F. Fouquet, J.M. Zhou, E. Ralston, K. Murray, F. Troalen, E. Magal,
O. Robain, M. Dubois-Dalcq, P. Aubourg, Expression of the adreno-
leukodystrophy protein in the human and mouse central nervous sys-
tem, Neurobiol. Dis. 3 (1997) 271–285.
[28] N. Troffer-Charlier, N. Doerflinger, E. Metzger, F. Fouquet, J.L. Man-
del, P. Aubourg, Mirror expression of adrenoleukodystrophy and
adrenoleukodystrophy related genes in mouse tissues and human cell
lines, Eur. J. Cell Biol. 75 (1998) 254–264.
[29] N. Garbi, N. Tiwari, F. Momburg, G.J. Hammerling, A major role
for tapasin as a stabilizer of the TAP peptide transporter and
consequences for MHC class I expression, Eur. J. Immunol. 33
(2003) 264–273.
[30] M. Ehrmann, R. Ehrle, E. Hofmann, W. Boos, A. Schlosser, The ABC
maltose transporter, Mol. Microbiol. 29 (1998) 685–694.
[31] D. Stock, C. Gibbons, I. Arechaga, A.G. Leslie, J.E. Walker, The
rotary mechanism of ATP synthase, Curr. Opin. Struct. Biol. 10
(2000) 672–679.[32] L.M. Hjelmeland, Solubilization of native membrane proteins, Meth-
ods Enzymol. 182 (1990) 253–264.
[33] R.H. Friesen, J. Knol, B. Poolman, Quaternary structure of the lactose
transport protein of Streptococcus thermophilus in the detergent-sol-
ubilized and membrane-reconstituted state, J. Biol. Chem. 275 (2000)
33527–33535.
[34] H. Schagger, K. Pfeiffer, Supercomplexes in the respiratory chains of
yeast and mammalian mitochondria, EMBO J. 19 (2000) 1777–1783.
[35] L.L. Jiang, S. Miyazawa, T. Hashimoto, Purification and properties of
rat D-3-hydroxyacyl-CoA dehydratase: D-3-hydroxyacyl-CoA dehy-
dratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein,
J. Biochem. 120 (1996) 633–641.
[36] M.K. Reddy, N. Usuda, M.N. Reddy, E.R. Kuczmarski, M.S. Rao,
J.K. Reddy, Purification, properties, and immunocytochemical local-
ization of human liver peroxisomal enoyl-CoA hydratase/3-hydrox-
yacyl-CoA dehydrogenase, Proc. Natl. Acad. Sci. U. S. A. 84 (1987)
3214–3218.
[37] P.B. Lazarow, Y. Fujiki, Biogenesis of peroxisomes, Annu. Rev. Cell
Biol. 1 (1985) 489–530.
[38] P.P. Van Veldhoven, G. Vanhove, S. Assselberghs, H.J. Eyssen,
G.P. Mannaerts, Substrate specificities of rat liver peroxisomal ac-
yl-CoA oxidases: palmitoyl-CoA oxidase (inducible acyl-CoA oxi-
dase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and
trihydroxycoprostanoyl-CoA oxidase, J. Biol. Chem. 267 (1992)
20065–20074.
[39] M.B. Baird, H.R. Massie, L.S. Birnbaum, Presence of a high-molec-
ular-weight form of catalase in enzyme purified from mouse liver,
Biochem. J. 163 (1977) 449–453.
[40] D.J.C. Pappin, P. Hojrup, A.J. Bleasby, Rapid identification of pro-
teins by peptide-mass fingerprinting, Curr. Biol. 3 (1993) 327–332.
